Abstract

Cutaneous Rosai-Dorfman Disease (CRDD) is an uncommon benign histiocytosis of unknown etiology. CRDD is oftentimes misdiagnosed because it has variable clinical manifestations, particularly in the absence of lymphadenopathy. We report a case of a 23-year-old African American woman presenting with clustered nodular plaques on her right thigh, buttocks, back, and chest for the past two years. History, clinical, histopathological, and immunochemistry findings corresponded with CRDD, and as such, she was treated with halobetasol propionate 0.05% cream twice daily.

Highlights

  • Rosai-Dorfman Disease (RDD) or sinus histiocytosis with massive lymphadenopathy (SHML) is a benign, self-limited proliferation of histiocytosis, first described by Rosai and Dorfman in 1969.1-3 RDD may involve the skin secondary to multi-organ involvement, or it may solely involve the skin without any other organ involvement

  • The disease is classified as Cutaneous Rosai-Dorfman Disease (CRDD).[1,2,3,4,5]

  • We report the case of a biopsy and immunohistochemistry proven CRDD, in a young African American woman

Read more

Summary

INTRODUCTION

Rosai-Dorfman Disease (RDD) or sinus histiocytosis with massive lymphadenopathy (SHML) is a benign, self-limited proliferation of histiocytosis, first described by Rosai and Dorfman in 1969.1-3 RDD may involve the skin secondary to multi-organ involvement, or it may solely involve the skin without any other organ involvement. In the latter scenario, the disease is classified as Cutaneous Rosai-Dorfman Disease (CRDD).[1,2,3,4,5] CRDD is believed to be a distinct entity because of its unique epidemiologic pattern and the absence of systemic manifestations.[4,5] It is considered a rare entity, with only a few cases reported in the literature.[5] We report the case of a biopsy and immunohistochemistry proven CRDD, in a young African American woman. New lesions developed on her chest, back, and buttocks, though some resolved

DISCUSSION
CONCLUSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call